Watch CBS News

Johnson & Johnson COVID 19 Vaccine Approved By FDA Advisory Panel

LOS ANGELES (CBSLA) — The U.S. Food and Drug Administration has given the greenlight to Johnson & Johnson's single-shot COVID-19 vaccine.

Governor Gavin Newsom says California has already begun ordering doses of Johnson & Johnson and the approval paves the way for the FDA to grant Emergency Use Authorization.

"The role of this vaccine is important because, just as a country, we need more than two vaccines," said Dr. Kenneth Kim of Johnson & Johnson. Kim is a Southern California doctor who is also a principal investigator on the Johnson & Johnson vaccine trial.

"Where it fits a really good niche is that this was a one-dose regimen, whereas the two vaccines, Pfizer and Moderna, which have already been approved are two-dose regimens," Kim said.

The FDA confirms that J&J's vaccine is slightly less effective that the Moderna and Pfizer shots overall, but showed 85 percent efficacy against severe illness and complete protection against COVID-19 deaths 28 days after getting the shot.

Dr. Kim says people with garden-variety allergies should not have any serious side effects.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.